4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-029223
Chief Medical Officer sold 2,000 shares at $81.38 ($162,760)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Bowden Christopher · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-05-08 | Exercise or conversion : show line 1 in the form | +2,000 | $35.16 | $70,320 | 2,881 | D |
| 2018-05-08 | Sale : show line 2 in the form | −2,000 | $81.38 | $162,760 | 881 | D |
| Open-market sales · 2,000 sh · avg $81.38 · $162,760 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-05-08 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −2,000 | 99,000 | D |
Loading xslF345X03/doc4.xml…